Molecular dissection of abnormal wound healing processes resulting in keloid disease

Wound Repair and Regeneration

Volumn 18, Issue 2, 2010, Pages 139-153

  Shih, Barbara ^a   Garside, Elloise ^a   McGrouther, Duncan Angus ^b   Bayat, Ardeshir ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; GAMMA INTERFERON; GROWTH FACTOR; INTERLEUKIN 6; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN BCL 2; SCATTER FACTOR; SCLEROPROTEIN; THROMBOSPONDIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VITRONECTIN;

APOPTOSIS; CD4 CD8 RATIO; CELL ACTIVITY; CELL CYCLE REGULATION; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; FIBROBLAST; GRANULATION TISSUE; HEMOSTASIS; HUMAN; KELOID; KERATINOCYTE; MACROPHAGE FUNCTION; MAST CELL; MOLECULAR DYNAMICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SCAR FORMATION; SKIN INFLAMMATION; WOUND HEALING IMPAIRMENT;

APOPTOSIS; CELL PROLIFERATION; CYTOKINES; HEMOSTASIS; HUMANS; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KELOID; MACROPHAGES; MAST CELLS; NEUTROPHILS; SKIN; SKIN PHYSIOLOGICAL PHENOMENA; WOUND HEALING;

EID: 77949905452     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2009.00553.x     Document Type: Review

References (157)

1. Brown BC, McKenna SP, Siddhi K, McGrouther DA, Bayat A. The hidden cost of skin scars: quality of life after skin scarring. J Plastic, Reconstr Aesthet Surg 2008 61 : 1049 1058.
2. Jagadeesan J, Bayat A. Transforming growth factor beta (TGF?) and keloid disease. Int J Surg 2007 5 : 278 285.
3. Bayat A, McGrouther DA, Ferguson MWJ. Skin scarring. Br Med J 2003 326 : 88 92.
4. Yang GP, Lim IJ, Phan TT, Lorenz HP, Longaker MT. From scarless fetal wounds to keloids: molecular studies in wound healing. Wound Repair Regen 2003 11 : 411 418.
5. Butler PD, Longaker MT, Yang GP. Current progress in keloid research and treatment. J Am Coll Surg 2008 206 : 731 741.
6. Funayama E, Chodon T, Oyama A, Sugihara T. Keratinocytes promote proliferation and inhibit apoptosis of the underlying fibroblasts: an important role in the pathogenesis of keloid. J Invest Dermatol 2003 121 : 1326 1331.
7. Dunkin CS, Pleat JM, Gillespie PH, Tyler MP, Roberts AH, McGrouther DA. Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers. Plast Reconstr Surg 2007 119 : 1722 1732 discussion 33-4.
8. English RS, Shenefelt PD. Keloids and hypertrophic scars. Dermatol Surg 1999 25 : 631 638.
9. Goodfellow A, Emmerson RW, Calvert HT. Rubinstein-Taybi syndrome and spontaneous keloids. Clin Exp Dermatol 1980 5 : 369 370.
10. Kurwa AR. Rubinstein-Taybi syndrome and spontaneous keloids. Clin Exp Dermatol 1979 4 : 251 254.
11. Mandal A, Imran D, Rao GS. Spontaneous keloids in siblings. Ir Med J 2004 97 : 250 251.
12. O'Sullivan ST, O'Shaughnessy M, O'Connor TP. Aetiology and management of hypertrophic scars and keloids. Ann R Coll Surg Engl 1996 78 (Part 1) : 168 175.
13. Mustoe TA, Cooter RD, Gold MH, Hobbs FD, Ramelet AA, Shakespeare PG, Stella M, Téot L, Wood FM, Ziegler UE. International Advisory Panel on Scar Management. International clinical recommendations on scar management. Plast Reconstr Surg 2002 110 : 560 571.
14. Robles DT, Berg D. Abnormal wound healing: keloids. Clin Dermatol 2007 25 : 26 32.
15. Robles DT, Moore E, Draznin M, Berg D. Keloids: pathophysiology and management. Dermatol Online J 2007 13 : 9.
16. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature 2008 453 : 314 321.
17. Sandulache VC, Parekh A, Li-Korotky H, Dohar JE, Hebda PA. Prostaglandin E2 inhibition of keloid fibroblast migration, contraction, and transforming growth factor (TGF)-beta1-induced collagen synthesis. Wound Repair Regen 2007 15 : 122 133.
18. Chipev CC, Simman R, Hatch G, Katz AE, Siegel DM, Simon M. Myofibroblast phenotype and apoptosis in keloid and palmar fibroblasts in vitro. Cell Death Differ 2000 7 : 166 176.
19. Luo S, Benathan M, Raffoul W, Panizzon RG, Egloff DV. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg 2001 107 : 87 96.
20. Ladin DA, Hou Z, Patel D, McPhail M, Olson JC, Saed GM, Fivenson DP. p53 and apoptosis alterations in keloids and keloid fibroblasts. Wound Repair Regen 1998 6 : 28 37.
21. Akasaka Y, Fujita K, Ishikawa Y, Asuwa N, Inuzuka K, Ishihara M, Ito M, Masuda T, Akishima Y, Zhang L, Ito K, Ishii T. Detection of apoptosis in keloids and a comparative study on apoptosis between keloids, hypertrophic scars, normal healed flat scars, and dermatofibroma. Wound Repair Regen 2001 9 : 501 506.
22. Marneros AG, Norris JE, Olsen BR, Reichenberger E. Clinical genetics of familial keloids. Arch Dermatol 2001 137 : 1429 1434.
23. Moustafa MF, Abdel-Fattah MA, Abdel-Fattah DC. Presumptive evidence of the effect of pregnancy estrogens on keloid growth. Case report. Plast Reconstr Surg 1975 56 : 450 453.
24. Subramanian R, White CJ, Sternbergh WC 3rd., Ferguson DL, Gilchrist IC. Nonhealing wound resulting from a foreign-body reaction to a radial arterial sheath. Catheter Cardiovasc Interv 2003 59 : 205 206.
25. Tredget EE, Nedelec B, Scott PG, Ghahary A. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg Clin North Am 1997 77 : 701 730.
26. Alonso PE, Rioja LF, Pera C. Keloids: a viral hypothesis. Med Hypotheses 2008 70 : 156 166.
27. Akaishi S, Ogawa R, Hyakusoku H. Keloid and hypertrophic scar: neurogenic inflammation hypotheses. Med Hypotheses 2008 71 : 32 8.
28. Zhang Q, Wu Y, Ann DK, Messadi DV, Tuan TL, Kelly AP, Bertolami CN, Le AD. Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts. J Invest Dermatol 2003 121 : 1005 1012.
29. Zachariae H. Delayed wound healing and keloid formation following argon laser treatment or dermabrasion during isotretinoin treatment. Br J Dermatol 1988 118 : 703 706.
30. Boyce DE, Ciampolini J, Ruge F, Murison MS, Harding KG. Inflammatory-cell subpopulations in keloid scars. Br J Plast Surg 2001 54 : 511 516.
31. Le AD, Zhang Q, Wu Y, Messadi DV, Akhondzadeh A, Nguyen AL, Aghaloo TL, Kelly AP, Bertolami CN. Elevated vascular endothelial growth factor in keloids: relevance to tissue fibrosis. Cells Tissues Organs 2004 176 : 87 94.
32. Xia W, Phan TT, Lim IJ, Longaker MT, Yang GP. Complex epithelial-mesenchymal interactions modulate transforming growth factor-beta expression in keloid-derived cells. Wound Repair Regen 2004 12 : 546 556.
33. Brown JJ, Bayat A. Genetic susceptibility to raised dermal scarring. Br J Dermatol 2009 161 : 8 18.
34. Chen W, Fu XB, Ge SL, Sun XQ, Zhou G, Zhao ZL, Sheng ZY. Development of gene microarray in screening differently expressed genes in keloid and normal-control skin. Chin Med J (England) 2004 117 : 877 881.
35. Luo X, Pan Q, Liu L, Chegini N. Genomic and proteomic profiling II: comparative assessment of gene expression profiles in leiomyomas, keloids, and surgically-induced scars. Reprod Biol Endocrinol 2007 5 : 35.
36. Satish L, Lyons-Weiler J, Hebda PA, Wells A. Gene expression patterns in isolated keloid fibroblasts. Wound Repair Regen 2006 14 : 463 470.
37. Seifert O, Bayat A, Geffers R, Dienus K, Buer J, Löfgren S, Matussek A. Identification of unique gene expression patterns within different lesional sites of keloids. Wound Repair Regen 2008 16 : 254 265.
38. Smith JC, Boone BE, Opalenik SR, Williams SM, Russell SB. Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways. J Invest Dermatol 2008 128 : 1298 1310.
39. Ladin DA, Garner WL, Smith DJ Jr. Excessive scarring as a consequence of healing. Wound Repair Regen 1995 3 : 6 14.
40. Baum CL, Arpey CJ. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg 2005 31 : 674 686 discussion 86.
41. Singer AJ, Simon M. Wound healing and skin substitutes. London : Springer, 2006.
42. Babu M, Diegelmann R, Oliver N. Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol 1989 9 : 1642 1650.
43. Tuan TL, Zhu JY, Sun B, Nichter LS, Nimni ME, Laug WE. Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. J Invest Dermatol 1996 106 : 1007 1011.
44. Huntington JA. Molecular recognition mechanisms of thrombin. J Thromb Haemost 2005 3 : 1861 1872.
45. Berkner KL. Blood clotting: general pathway. Encyclopedia of life sciences. Chichester : John Wiley & Sons Ltd., 2001.
46. Campbell PG, Durham SK, Hayes JD, Suwanichkul A, Powell DR. Insulin-like growth factor-binding protein-3 binds fibrinogen and fibrin. J Biol Chem 1999 274 : 30215 30221.
47. Sahni A, Odrljin T, Francis CW. Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem 1998 273 : 7554 7559.
48. Tuan TL, Wu H, Huang EY, Chong SS, Laug W, Messadi D, Kelly P, Le A. Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures. Am J Pathol 2003 162 : 1579 1589.
49. Drew AF, Liu H, Davidson JM, Daugherty CC, Degen JL. Wound-healing defects in mice lacking fibrinogen. Blood 2001 97 : 3691 3698.
50. Hattori N, Degen JL, Sisson TH, Liu H, Moore BB, Pandrangi RG, Simon RH, Drew AF. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J Clin Invest 2000 106 : 1341 1350.
51. Schafer M, Werner S. Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol 2008 9 : 628 638.
52. Martin P, Leibovich SJ. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 2005 15 : 599 607.
53. Hubner G, Brauchle M, Smola H, Madlener M, Fassler R, Werner S. Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine 1996 8 : 548 556.
54. Hart J. Inflammation. 1: its role in the healing of acute wounds. J Wound Care 2002 11 : 205 209.
55. Haisa M, Okochi H, Grotendorst GR. Elevated levels of PDGF alpha receptors in keloid fibroblasts contribute to an enhanced response to PDGF. J Invest Dermatol 1994 103 : 560 563.
56. Wu Y, Zhang Q, Ann DK, Akhondzadeh A, Duong HS, Messadi DV, Le AD. Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts. Am J Physiol Cell Physiol 2004 286 : C905 12.
57. Fujiwara M, Muragaki Y, Ooshima A. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity. Arch Dermatol Res 2005 297 : 161 169.
58. Lee TY, Chin GS, Kim WJ, Chau D, Gittes GK, Longaker MT. Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann Plast Surg 1999 43 : 179 184.
59. Simpson DM, Ross R. The neutrophilic leukocyte in wound repair a study with antineutrophil serum. J Clin Invest 1972 51 : 2009 2023.
60. Dovi JV, He LK, DiPietro LA. Accelerated wound closure in neutrophil-depleted mice. J Leukoc Biol 2003 73 : 448 455.
61. Egozi EI, Ferreira AM, Burns AL, Gamelli RL, DiPietro LA. Mast cells modulate the inflammatory but not the proliferative response in healing wounds. Wound Repair Regen 2003 11 : 46 54.
62. Leibovich SJ, Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol 1975 78 : 71 100.
63. Szpaderska AM, Egozi EI, Gamelli RL, DiPietro LA. The effect of thrombocytopenia on dermal wound healing. J Invest Dermatol 2003 120 : 1130 1137.
64. Hopkinson-Woolley J, Hughes D, Gordon S, Martin P. Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse. J Cell Sci 1994 107 (Part 5) : 1159 1167.
65. Martin P, D'Souza D, Martin J, Grose R, Cooper L, Maki R, McKercher SR. Wound healing in the PU.1 null mouse-tissue repair is not dependent on inflammatory cells. Curr Biol 2003 13 : 1122 1128.
66. Craig SS, DeBlois G, Schwartz LB. Mast cells in human keloid, small intestine, and lung by an immunoperoxidase technique using a murine monoclonal antibody against tryptase. Am J Pathol 1986 124 : 427 435.
67. Fong EP, Bay BH. Keloids - the sebum hypothesis revisited. Med Hypotheses 2002 58 : 264 269.
68. Boyce DE, Jones WD, Ruge F, Harding KG, Moore K. The role of lymphocytes in human dermal wound healing. Br J Dermatol 2000 143 : 59 65.
69. Elias JA, Freundlich B, Kern JA, Rosenbloom J. Cytokine networks in the regulation of inflammation and fibrosis in the lung. Chest 1990 97 : 1439 1445.
70. Maarouf M, Schleicher U, Schmachtenberg A, Ammon J. Radiotherapy in the management of keloids. Clinical experience with electron beam irradiation and comparison with X-ray therapy. Strahlenther Onkol 2002 178 : 330 335.
71. McCauley RL, Chopra V, Li YY, Herndon DN, Robson MC. Altered cytokine production in black patients with keloids. J Clin Immunol 1992 12 : 300 308.
72. Jimenez SA, Freundlich B, Rosenbloom J. Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest 1984 74 : 1112 1116.
73. Duncan MR, Berman B. Differential regulation of glycosaminoglycan, fibronectin, and collagenase production in cultured human dermal fibroblasts by interferon-alpha, -beta, and -gamma. Arch Dermatol Res 1989 281 : 11 8.
74. Granstein RD, Rook A, Flotte TJ, Haas A, Gallo RL, Jaffe HS, Amento EP. A controlled trial of intralesional recombinant interferon-gamma in the treatment of keloidal scarring. Clinical and histologic findings. Arch Dermatol 1990 126 : 1295 1302.
75. Tosa M, Ghazizadeh M, Shimizu H, Hirai T, Hyakusoku H, Kawanami O. Global gene expression analysis of keloid fibroblasts in response to electron beam irradiation reveals the involvement of interleukin-6 pathway. J Invest Dermatol 2005 124 : 704 713.
76. Ghazizadeh M, Tosa M, Shimizu H, Hyakusoku H, Kawanami O. Functional implications of the IL-6 signaling pathway in keloid pathogenesis. J Invest Dermatol 2007 127 : 98 105.
77. Xue H, McCauley RL, Zhang W. Elevated interleukin-6 expression in keloid fibroblasts. J Surg Res 2000 89 : 74 7.
78. Gallucci RM, Simeonova PP, Matheson JM, Kommineni C, Guriel JL, Sugawara T, Luster MI. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J 2000 14 : 2525 2531.
79. Kischer CW, Hendrix MJ. Fibronectin (FN) in hypertrophic scars and keloids. Cell Tissue Res 1983 231 : 29 37.
80. Friedman DW, Boyd CD, Mackenzie JW, Norton P, Olson RM, Deak SB. Regulation of collagen gene expression in keloids and hypertrophic scars. J Surg Res 1993 55 : 214 222.
81. Fujiwara M, Muragaki Y, Ooshima A. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Br J Dermatol 2005 153 : 295 300.
82. Amadeu TP, Braune AS, Porto LC, Desmouliere A, Costa AM. Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids. Wound Repair Regen 2004 12 : 169 174.
83. Alaish SM, Yager DR, Diegelmann RF, Cohen IK. Hyaluronic acid metabolism in keloid fibroblasts. J Pediatr Surg 1995 30 : 949 952.
84. Meyer LJ, Russell SB, Russell JD, Trupin JS, Egbert BM, Shuster S, Stern R. Reduced hyaluronan in keloid tissue and cultured keloid fibroblasts. J Invest Dermatol 2000 114 : 953 959.
85. Zhao J, Zhang N, Prestwich GD, Wen X. Recruitment of endogenous stem cells for tissue repair. Macromol Biosci 2008 8 : 836 842.
86. Schmidt A, Ladage D, Schinköthe T, Klausmann U, Ulrichs C, Klinz FJ, Brixius K, Arnhold S, Desai B, Mehlhorn U, Schwinger RH, Staib P, Addicks K, Bloch W. Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells 2006 24 : 1750 1758.
87. Moon JH, Kwak SS, Park G, Jung HY, Yoon BS, Park J, Ryu KS, Choi SC, Maeng I, Kim B, Jun EK, Kim S, Kim A, Oh S, Kim H, Kim KD, You S. Isolation and characterization of multipotent human keloid-derived mesenchymal-like stem cells. Stem Cells Dev 2008 17 : 713 724.
88. Akino K, Akita S, Yakabe A, Mineda T, Hayashi T, Hirano A. Human mesenchymal stem cells may be involved in keloid pathogenesis. Int J Dermatol 2008 47 : 1112 1117.
89. Midwood KS, Williams LV, Schwarzbauer JE. Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol 2004 36 : 1031 1037.
90. Lim IJ, Phan TT, Bay BH, Qi R, Huynh H, Tan WT, Lee ST, Longaker MT. Fibroblasts cocultured with keloid keratinocytes: normal fibroblasts secrete collagen in a keloidlike manner. Am J Physiol Cell Physiol 2002 283 : C212 22.
91. Abergel RP, Pizzurro D, Meeker CA, Lask G, Matsuoka LY, Minor RR, Chu ML, Uitto J. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol 1985 84 : 384 390.
92. Khoo YT, Ong CT, Mukhopadhyay A, Han HC, Do DV, Lim IJ, Phan TT. Upregulation of secretory connective tissue growth factor (CTGF) in keratinocyte-fibroblast coculture contributes to keloid pathogenesis. J Cell Physiol 2006 208 : 336 343.
93. Li J, Zhang YP, Kirsner RS. Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc Res Tech 2003 60 : 107 114.
94. Gira AK, Brown LF, Washington CV, Cohen C, Arbiser JL. Keloids demonstrate high-level epidermal expression of vascular endothelial growth factor. J Am Acad Dermatol 2004 50 : 850 853.
95. Kischer CW. The microvessels in hypertrophic scars, keloids and related lesions: a review. J Submicrosc Cytol Pathol 1992 24 : 281 296.
96. Kischer CW, Thies AC, Chvapil M. Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids. Hum Pathol 1982 13 : 819 824.
97. Thomas DW, Hopkinson I, Harding KG, Shepherd JP. The pathogenesis of hypertrophic/keloid scarring. Int J Oral Maxillofac Surg 1994 23 : 232 236.
98. Beer TW. Keloids are not angiogenic lesions. J Am Acad Dermatol 2005 53 : 1097.
99. Caulfield RH, Tyler MP, Austyn JM, Dziewulski P, McGrouther DA. The relationship between protease/anti-protease profile, angiogenesis and re-epithelialisation in acute burn wounds. Burns 2008 34 : 474 486.
100. Messadi DV, Le A, Berg S, Huang G, Zhuang W, Bertolami CN. Effect of TGF-beta 1 on PDGF receptors expression in human scar fibroblasts. Front Biosci 1998 3 : a16 22.
101. Harper RA. Keloid fibroblasts in culture: abnormal growth behaviour and altered response to the epidermal growth factor. Cell Biol Int Rep 1989 13 : 325 335.
102. Kikuchi K, Kadono T, Takehara K. Effects of various growth factors and histamine on cultured keloid fibroblasts. Dermatology 1995 190 : 4 8.
103. Satish L, Babu M, Tran KT, Hebda PA, Wells A. Keloid fibroblast responsiveness to epidermal growth factor and activation of downstream intracellular signaling pathways. Wound Repair Regen 2004 12 : 183 192.
104. Abreu JG, Ketpura NI, Reversade B, De Robertis EM. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 2002 4 : 599 604.
105. Igarashi A, Okochi H, Bradham DM, Grotendorst GR. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 1993 4 : 637 645.
106. Faler BJ, Macsata RA, Plummer D, Mishra L, Sidawy AN. Transforming growth factor-beta and wound healing. Perspect Vasc Surg Endovasc Ther 2006 18 : 55 62.
107. Bettinger DA, Yager DR, Diegelmann RF, Cohen IK. The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg 1996 98 : 827 833.
108. Peltonen J, Hsiao LL, Jaakkola S, Sollberg S, Aumailley M, Timpl R, Chu ML, Uitto J. Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-beta 1 mRNA. J Invest Dermatol 1991 97 : 240 248.
109. Scott PG, Dodd CM, Tredget EE, Ghahary A, Rahemtulla F. Immunohistochemical localization of the proteoglycans decorin, biglycan and versican and transforming growth factor-beta in human post-burn hypertrophic and mature scars. Histopathology 1995 26 : 423 431.
110. Yu H, Bock O, Bayat A, Ferguson MW, Mrowietz U. Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring. J Plast Reconstr Aesthet Surg 2006 59 : 221 229.
111. Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995 108 (Part 3) : 985 1002.
112. O'Kane S. Wound remodelling and scarring. J Wound Care 2002 11 : 296 299.
113. Frantz FW, Bettinger DA, Haynes JH, Johnson DE, Harvey KM, Dalton HP, Yager DR, Diegelmann RF, Cohen IK. Biology of fetal repair: the presence of bacteria in fetal wounds induces an adult-like healing response. J Pediatr Surg 1993 28 : 428 433 discussion 33-4.
114. Whitby DJ, Ferguson MW. Immunohistochemical localization of growth factors in fetal wound healing. Dev Biol 1991 147 : 207 215.
115. Daian T, Ohtsuru A, Rogounovitch T, Ishihara H, Hirano A, Akiyama-Uchida Y, Saenko V, Fujii T, Yamashita S. Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts. J Invest Dermatol 2003 120 : 956 962.
116. Ishihara H, Yoshimoto H, Fujioka M, Murakami R, Hirano A, Fujii T, Ohtsuru A, Namba H, Yamashita S. Keloid fibroblasts resist ceramide-induced apoptosis by overexpression of insulin-like growth factor I receptor. J Invest Dermatol 2000 115 : 1065 1071.
117. Ohtsuru A, Yoshimoto H, Ishihara H, Namba H, Yamashita S. Insulin-like growth factor-I (IGF-I)/IGF-I receptor axis and increased invasion activity of fibroblasts in keloid. Endocr J 2000 47 (Suppl.) : S41 4.
118. Phan TT, See P, Tran E, Nguyen TT, Chan SY, Lee ST, Huynh H. Suppression of insulin-like growth factor signalling pathway and collagen expression in keloid-derived fibroblasts by quercetin: its therapeutic potential use in the treatment and/or prevention of keloids. Br J Dermatol 2003 148 : 544 552.
119. Yoshimoto H, Ishihara H, Ohtsuru A, Akino K, Murakami R, Kuroda H, Namba H, Ito M, Fujii T, Yamashita S. Overexpression of insulin-like growth factor-1 (IGF-I) receptor and the invasiveness of cultured keloid fibroblasts. Am J Pathol 1999 154 : 883 889.
120. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993 122 : 103 111.
121. O'Kane S, Ferguson MW. Transforming growth factor beta s and wound healing. Int J Biochem Cell Biol 1997 29 : 63 78.
122. Toriseva M, Kahari VM. Proteinases in cutaneous wound healing. Cell Mol Life Sci 2009 66 : 203 224.
123. Tuan TL, Nichter LS. The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 1998 4 : 19 24.
124. Lovvorn HN III., Cheung DT, Nimni ME, Perelman N, Estes JM, Adzick NS. Relative distribution and crosslinking of collagen distinguish fetal from adult sheep wound repair. J Pediatr Surg 1999 34 : 218 223.
125. Niessen FB, Spauwen PH, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 1999 104 : 1435 1458.
126. Adelmann-Grill BC, Hein R, Wach F, Krieg T. Inhibition of fibroblast chemotaxis by recombinant human interferon gamma and interferon alpha. J Cell Physiol 1987 130 : 270 275.
127. Ala-Kokko L, Rintala A, Savolainen ER. Collagen gene expression in keloids: analysis of collagen metabolism and type I, III, IV, and V procollagen mRNAs in keloid tissue and keloid fibroblast cultures. J Invest Dermatol 1987 89 : 238 244.
128. Leake D, Doerr TD, Scott G. Expression of urokinase-type plasminogen activator and its receptor in keloids. Arch Otolaryngol Head Neck Surg 2003 129 : 1334 1338.
129. Neely AN, Clendening CE, Gardner J, Greenhalgh DG, Warden GD. Gelatinase activity in keloids and hypertrophic scars. Wound Repair Regen 1999 7 : 166 171.
130. Oriente A, Fedarko NS, Pacocha SE, Huang SK, Lichtenstein LM, Essayan DM. Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts. J Pharmacol Exp Ther 2000 292 : 988 994.
131. Uchida G, Yoshimura K, Kitano Y, Okazaki M, Harii K. Tretinoin reverses upregulation of matrix metalloproteinase-13 in human keloid-derived fibroblasts. Exp Dermatol 2003 12 (Suppl. 2) : 35 42.
132. Greenhalgh DG. The role of apoptosis in wound healing. Int J Biochem Cell Biol 1998 30 : 1019 1030.
133. Chodon T, Sugihara T, Igawa HH, Funayama E, Furukawa H. Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance. Am J Pathol 2000 157 : 1661 1669.
134. Messadi DV, Le A, Berg S, Jewett A, Wen Z, Kelly P, Bertolami CN. Expression of apoptosis-associated genes by human dermal scar fibroblasts. Wound Repair Regen 1999 7 : 511 517.
135. Appleton I, Brown NJ, Willoughby DA. Apoptosis, necrosis, and proliferation: possible implications in the etiology of keloids. Am J Pathol 1996 149 : 1441 1447.
136. Sayah DN, Soo C, Shaw WW, Watson J, Messadi D, Longaker MT, Zhang X, Ting K. Downregulation of apoptosis-related genes in keloid tissues. J Surg Res 1999 87 : 209 216.
137. Dyczynska E, Syta E, Sun D, Zolkiewska A. Breast cancer-associated mutations in metalloprotease disintegrin ADAM12 interfere with the intracellular trafficking and processing of the protein. Int J Cancer 2008 122 : 2634 2640.
138. Frohlich C, Albrechtsen R, Dyrskjot L, Rudkjaer L, Orntoft TF, Wewer UM. Molecular profiling of ADAM12 in human bladder cancer. Clin Cancer Res 2006 12 : 7359 7368.
139. Le Pabic H, Bonnier D, Wewer UM, Coutand A, Musso O, Baffet G, Clément B, Théret N. ADAM12 in human liver cancers: TGF-beta-regulated expression in stellate cells is associated with matrix remodeling. Hepatology 2003 37 : 1056 1066.
140. Akasaka Y, Ishikawa Y, Ono I, Fujita K, Masuda T, Asuwa N, Inuzuka K, Kiguchi H, Ishii T. Enhanced expression of caspase-3 in hypertrophic scars and keloid: induction of caspase-3 and apoptosis in keloid fibroblasts in vitro. Lab Invest 2000 80 : 345 357.
141. Akasaka Y, Ito K, Fujita K, Komiyama K, Ono I, Ishikawa Y, Akishima Y, Sato H, Ishii T. Activated caspase expression and apoptosis increase in keloids: cytochrome c release and caspase-9 activation during the apoptosis of keloid fibroblast lines. Wound Repair Regen 2005 13 : 373 382.
142. Nassiri M, Woolery-Lloyd H, Ramos S, Jacob SE, Gugic D, Viciana A, Romanelli P, Elgart G, Berman B, Vincek V. Gene expression profiling reveals alteration of caspase 6 and 14 transcripts in normal skin of keloid-prone patients. Arch Dermatol Res 2009 301 : 183 188.
143. Garner WL. Epidermal regulation of dermal fibroblast activity. Plast Reconstr Surg 1998 102 : 135 139.
144. Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2002 2 : 647 656.
145. Kuwana T, Mackey MR, Perkins G, Ellisman MH, Latterich M, Schneiter R, Green DR, Newmeyer DD. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 2002 111 : 331 342.
146. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001 292 : 727 730.
147. Yip KW, Reed JC. Bcl-2 family proteins and cancer. Oncogene 2008 27 : 6398 6406.
148. Lu F, Gao J, Ogawa R, Hyakusoku H, Ou C. Biological differences between fibroblasts derived from peripheral and central areas of keloid tissues. Plast Reconstr Surg 2007 120 : 625 630.
149. Teofoli P, Barduagni S, Ribuffo M, Campanella A, De Pita O, Puddu P. Expression of Bcl-2, p53, c-jun and c-fos protooncogenes in keloids and hypertrophic scars. J Dermatol Sci 1999 22 : 31 7.
150. Woods DB, Vousden KH. Regulation of p53 function. Exp Cell Res 2001 264 : 56 66.
151. Saed GM, Ladin D, Olson J, Han X, Hou Z, Fivenson D. Analysis of p53 gene mutations in keloids using polymerase chain reaction-based single-strand conformational polymorphism and DNA sequencing. Arch Dermatol 1998 134 : 963 967.
152. Tanaka A, Hatoko M, Tada H, Iioka H, Niitsuma K, Miyagawa S. Expression of p53 family in scars. J Dermatol Sci 2004 34 : 17 24.
153. Witt E, Maliri A, McGrouther DA, Bayat A. RAC activity in keloid disease: comparative analysis of fibroblasts from margin of keloid to its surrounding normal skin. Eplasty 2008 8 : e19.
154. Ghazizadeh M. Essential role of IL-6 signaling pathway in keloid pathogenesis. J Nippon Med Sch 2007 74 : 11 22.
155. Bayat A, Bock O, Mrowietz U, Ollier WE, Ferguson MW. Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels. Plast Reconstr Surg 2003 111 : 535 543 discussion 44-6.
156. Bayat A, Arscott G, Ollier WE, Ferguson MW, McGrouther DA. Description of site-specific morphology of keloid phenotypes in an Afrocaribbean population. Br J Plast Surg 2004 57 : 122 133.
157. Cohen IK, Beaven MA, Horakova Z, Keiser HR. Histamine and collagen synthesis in keloid and hypertrophic scar. Surg Forum 1972 23 : 509 510.